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Kalirin is a multidomain guanine nucleotide exchange factor (GEF) that activates Rho proteins, inducing
cytoskeletal rearrangement in neurons. Although much is known about the effects of Kalirin on Rho GTPases
and neuronal morphology, little is known about the association of Kalirin with the receptor/signaling systems
that affect neuronal morphology. Our experiments demonstrate that Kalirin binds to and colocalizes with the
TrkA neurotrophin receptor in neurons. In PC12 cells, inhibition of Kalirin expression using antisense RNA
decreased nerve growth factor (NGF)-induced TrkA autophosphorylation and process extension. Kalirin
overexpression potentiated neurotrophin-stimulated TrkA autophosphorylation and neurite outgrowth in
PC12 cells at a low concentration of NGF. Furthermore, elevated Kalirin expression resulted in catalytic
activation of TrkA, as demonstrated by in vitro kinase assays and increased NGF-stimulated cellular activation
of Rac, Mek, and CREB. Domain mapping demonstrated that the N-terminal Kalirin pleckstrin homology
domain mediates the interaction with TrkA. The effects of Kalirin on TrkA provide a molecular basis for the
requirement of Kalirin in process extension from PC12 cells and for previously observed effects on axonal
extension and dendritic maintenance. The interaction of TrkA with the pleckstrin homology domain of Kalirin
may be one example of a general mechanism whereby receptor/Rho GEF pairings play an important role in
receptor tyrosine kinase activation and signal transduction.
Small G proteins act as molecular switches controlling a
wide array of cellular processes in organisms ranging from
bacteria to humans. The Rho subgroup of G proteins is most
notably involved in regulation of the actin cytoskeleton (7).
Rho proteins are activated by guanine nucleotide exchange
factors (GEFs), which induce the release of bound GDP and
allow the binding of GTP; the Rho-GTP complexes can then
bind to and activate a series of effector proteins. The activity of
Rho proteins is regulated by GTPase-activating proteins,
which induce the hydrolysis of bound GTP, and by guanine
nucleotide dissociation inhibitors that sequester G proteins
bound to GDP or GTP.
In addition to their role in cytoskeletal regulation, recent
evidence has established an association of Rho proteins,
GTPase-activating proteins, and GEFs with several cell surface
receptors and their signaling pathways. For example, Vav links
the FcεRI receptor to stress-activated protein kinase (c-Jun
N-terminal kinase) activation (51). However, no RhoGEF is
known to interact with the TrkA neurotrophin receptor.
Several pieces of evidence suggest that the RhoGEF Kalirin
may play a role in TrkA receptor function. Antisense Kalirin
oligonucleotides block initiation and outgrowth of axons from
sympathetic neuron primary cultures grown in the presence of
nerve growth factor (NGF) (32). A yeast two-hybrid screen
identified Kalirin as a GIPC (GIAP-interacting protein C ter-
minus) interactor, and GIPC associates with TrkA (26, 39).
Kalirin binds to Crk, an adaptor protein that links TrkA to
Rap1 activation and subsequent activation of the mitogen-
activated protein kinase (MAPK) pathway (57; M. R. Schiller,
K. Chakrabarti, G. F. King, N. I. Schiller, B. A. Eipper, and M.
Maciejewski, submitted for publication). TrkA stimulation in-
duces activation of Rac, and Kalirin activates Rac (37, 40).
Finally, Kalirin and TrkA are both localized in presynaptic and
postsynaptic terminals (5, 10, 28). These experiments directed
us to investigate the relationship of Kalirin with TrkA.
MATERIALS AND METHODS
Cell culture, primary olfactory bulb cultures, and transfection. PC12 and -293
cells were grown in Dulbecco’s modified Eagle medium (DMEM)-F12 medium
containing 120 g/ml penicillin, 200 g/ml streptomycin sulfate, 600 g/ml glu-
tamine, 25 mM HEPES, and 10% fetal bovine serum. Primary olfactory bulb
cultures were prepared from dissected P1 rat olfactory bulbs. Olfactory bulbs
were washed three times with DMEM-F12 containing fatty-acid-free bovine
serum albumin (BSA) (1 mg/ml) and transferrin (100 g/ml), diced, and incu-
bated with the same DMEM-F12 medium containing 3 mg/ml trypsin and 4
mg/ml DNase for 20 min at 37°C to dissociate cells. After titration and filtration
through a cell strainer (70-m mesh), strained cells were plated on poly-L-lysine-
coated dishes and grown for 5 to 9 days prior to transfection and immunostain-
ing. All experiments reported in this paper were repeated at least three times
with similar results.
Transient transfection of PC12 and 293 cells for reporter assays, Western blot
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analysis, immunostaining, and neurite outgrowth experiments was performed
using Lipofectamine 2000 and Optimem as described by the manufacturer (In-
vitrogen). The Lipofectamine 2000/DNA ratio for all experiments was 2.5. Cells
were transfected for 4 h, grown in DMEM-F12–10% fetal calf serum for 24 h,
and serum starved in DMEM-F12–1% BSA supplemented with 120 g/ml pen-
icillin, 200 g/ml streptomycin sulfate, and 25 mM HEPES for 16 h before
induction with 2 or 50 ng/ml NGF (Becton Dickinson) where indicated. Olfactory
bulb neurons were transfected with Fugene 6 according to the manufacturer’s
protocol (Roche Diagnostics). Western blot analysis was performed by a stan-
dard approach using 4 to 15% gradient gels (Bio-Rad or Invitrogen) and 1%
blocking solution (Roche Diagnostics).
Coimmunoprecipitation from mouse brain and transfected cells. Embryonic
mouse brains (embryonic day 17 [E17]) were isolated as previously described
(11) and homogenized (10%, wt/vol) in COIP buffer (50 mM HEPES, pH 7.6,
150 mM NaCl, 10% glycerol, and 0.5% Triton X-100) with protease and phos-
phatase inhibitors (18). After centrifugation, lysates (200 g) were incubated
with 2 g of TrkA (Santa Cruz Biotech) or a control antibody and COIP buffer
(1.0 ml) for 2 h with agitation at 4°C. Samples were centrifuged at 15,000  g for
5 min to remove debris, and immune complexes were absorbed to protein
G-Sepharose beads (40 l) for 1 h at 4°C with shaking. Beads were washed three
times with COIP buffer, and bound proteins were boiled in sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer. The
presence of Kalirin and TrkA in the immunoprecipitated samples was revealed
by Western blot analysis with a pan-Kalirin antiserum (37) and an antibody to a
C-terminal peptide of TrkA (Sigma; T9566).
For coimmunoprecipitation from transfected cells, lysates from 293 cells co-
transfected with His/Myc-tagged Kalirin 5 (Kal5) and TrkA (CMX-TrkA) ex-
pression constructs were prepared in COIP buffer with protease and phosphatase
inhibitors. Kal5 present in lysates was immunoprecipitated with the anti-myc
antibody 9E10; for a negative control, an isotype control immunoglobulin G1
(IgG1) antibody was used (23). Samples were analyzed for immunoprecipitation
of Kal5 and coimmunoprecipitation of P-TrkA using a TrkA antibody.
Immunofluoresence microscopy and neurite outgrowth assays. Transfected
PC12 cells and neurons were immunostained using standard approaches as
previously described (44). Where indicated, cells were treated with NGF. Im-
munostained cells and those transfected with green fluorescent protein (GFP)
expression constructs were visualized by fluorescence microscopy using an in-
verted Nikon fluorescence microscope. Images were obtained using a Hamamatsu
digital camera and Improvision Openlabs 3.1.4 software. Where indicated, im-
ages were collected using an Improvision Orbit Z-stepmotor and deconvolved
using Improvision Volocity software.
For quantitation of neurite outgrowth, images of PC12 cells transfected with
pCMS.EGFP (Clontech), pCMS.EGFP/Kal-as, or pCMS.Kal5 were treated with
2 or 50 ng/ml NGF for 2 days where indicated, images were collected, and
transfected cells with neurites longer or shorter than one cell body were counted
(28). For quantitation of P-TrkA immunostaining in neurons, neurons expressing
GFP and strongly immunostained with P-TrkA were counted for samples trans-
fected with pCMS.EGFP, pCMS.EGFP/Kal-as, and pCMS.EGFP/Control-
(PAM)-as. For statistical analysis of neurite outgrowth and P-TrkA immuno-
staining in neurons, samples from cells transfected with different constructs or
treated with NGF were blinded to the observer and rank ordered, and significant
differences were determined using a nonparametric Kruskal-Wallis test (http:
//faculty.vassar.edu/lowry/VassarStats.html). At least 50 cells were counted for
each category.
TrkA kinase assays. Kinase reactions were performed in 25 mM HEPES, pH
7.4, 10 mM MgCl2, 2.5 mM MnCl2, 50 M sodium orthovanadate, 0.5 mM
dithiothreitol, 0.2% Triton X-100, 40 g/ml BSA, and 25 M ATP with 62.5
Ci/ml [-32P]ATP (Amersham) in a total volume of 40 l at 25°C. TrkA
autokinase reactions were performed in the presence of ATP alone, whereas 1
mM synthetic peptide corresponding to residues 309 to 326 of Shc (KKRELPD
DPSYVNVQNLDKK) was used as an exogenous substrate. Autokinase reac-
tions were terminated after 10 min by boiling, products were separated in an 8%
SDS-PAGE gel and transferred to a polyvinylidene difluoride membrane, and
the bound radioactivity was detected by autoradiography. Peptide reactions were
terminated after 10 min with 8.5% H3PO4, and incorporation of the radiolabel
into the peptide was quantified as previously described (13). Relative amounts of
TrkA in immunoprecipitates were quantified by Western blotting using a Kodak
Image Station 440. Significant differences were determined using a one-tailed t
test.
Signal transduction reporter assays. Signal transduction reporter assays were
performed using the trans-reporter system (Stratagene). For these assays, 293
cells (105 cells in 20-mm wells) were cotransfected with two plasmids for the
reporter system (100 ng pFR.Luc and 10 ng pFA2.CREB), a TrkA expression
construct (25 ng CMX-TrkA), differing amounts of a Kal5 expression construct
(0 to 400 ng pEAK10.HisMyc.Kal5), and a construct used for normalizing trans-
fection efficiency (pCDNA.Gal) and supplemented with an empty pEAK10
vector (Edge Biosystems) such that all samples had the same amount of DNA.
Luciferase activity was measured from cell lysates by using the substrate and
assay conditions described by the manufacturer (Promega). Transfection effi-
ciency was normalized to cotransfected -galactosidase levels using the Galacton
luminescent -galactosidase substrate (Tropix, Bedford, MA). Expression of
transfected TrkA and Kalirin was confirmed by Western blot analysis. Luciferase
assays were performed in triplicate, and standard deviations are reported for
triplicate observations and multiple experiments. Significant differences were
determined using one-way analysis of variance (ANOVA).
Several control experiments were performed to optimize conditions for the
luciferase reporter assay (data not shown). Reporter plasmids were titrated to
identify conditions for low basal stimulation and high induction of the reporter
with the catalytic subunit of protein kinase A (pFC.PKA). The TrkA expression
construct was titrated from 10 ng to 1 g to determine levels that produced the
lowest basal versus highest NGF-stimulated reporter activation (25 ng). NGF
levels were titrated to identify those that produced maximal reporter activation
(25 ng/ml). A time course of NGF stimulation showed near-maximal CREB
activation after 6 h of NGF treatment, which was used in subsequent experi-
ments.
GST pulldown experiments. For mapping TrkA binding sites in Kalirin, glu-
tatione S-transferase (GST) fusion proteins for fragments of Kal5 were prepared.
Different Kal5 domains were spectrin 5-9 (residues M624 to R1273), GST-DBL
homology (DH) (residues K1274 to V1452), GST-pleckstrin homology (PH) (res-
idues S1453 to R1575; also called GST-PH1), and GST DH/PH (residues K1274 to
R1575). Numbering is based on the rat Kal12a sequence (AF232669). A construct
for expression of a GST fusion protein with the Kal7 C terminus was described
previously (39). For PH domain specificity experiments, GST-KalPH2 (residues
L2065 to R2218), GST-TrioPH1 (residues L1399 to K1550), and GST-TrioPH2
(residues C2077 to G2233) were prepared; numbering for Trio is based on the
human Trio sequence (U42390). cDNA fragments were subcloned into pGEX6P
in frame with GST.
GST fusion proteins were expressed in Escherichia coli BL21 or Rosetta
(Novagen) and purified using glutathione Sepharose as previously described
(32). Lysates containing TrkA were prepared from 293 cells transfected with the
CMX-TrkA plasmid. Cells were extracted in TMT buffer [20 mM sodium–N-
tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES), pH 7.4; 10 mM
mannitol, and 1% Triton X-100] containing protease inhibitors (18, 34, 55).
Lysates (100 l) were incubated with GST or GST fusion proteins (5 g) in a
total volume of 1.0 ml for 1 h at 4°C with agitation and then applied to gluta-
thione Sepharose beads (40 l). After three washes with TMT, protein com-
plexes were boiled in SDS-PAGE sample buffer and analyzed by Western
blotting using TrkA (Sigma or Chemicon, Temecula, CA) and phospho-TrkA
(Tyr499) (Cell Signaling Inc.) antibodies where indicated. Loading of each fusion
protein was determined by Coomassie staining.
Rac activation in PC12 cells. Activation of Rac was analyzed using a GST-
effector binding assay. Transfected PC12 cells were stimulated with 50 ng/ml
NGF for 0, 2, or 10 min, and cell lysates were prepared in MLB buffer (25 mM
HEPES, 150 mM sodium chloride, 1% Nonidet P-40, 10 mM magnesium chlo-
ride, 1 mM EDTA, 10% glycerol, 0.3 mg/ml phenylmethylsulfonyl fluoride, 1.0
mM sodium vanadate, and protease inhibitors [pH 7.5]) (18). Lysates were
incubated with glutathione-agarose beads containing the immobilized P21-acti-
vated kinase p21 binding domain (PAK-PBD) (residues 67 to 150; 10.0 g), and
unbound protein was removed by three washes with MLB buffer. For controls, 50
l of cell extract was incubated with 10 mM EDTA and 0.1 mM GTPS (positive
control) or 1 mM GDP (negative control) for 20 min at 30°C, cooled, and
supplemented with 10 mM magnesium chloride prior to incubation with PAK-
PBD-GST bound to glutathione-agarose beads. Following denaturation, bound
Rac was analyzed by Western blot analysis and quantitated by densitometry using
Image J (National Institutes of Health).
RESULTS
Kalirin plays an important role in NGF-induced differenti-
ation of PC12 cells. Our previous experiments microinjecting
sympathetic neurons were not amenable to biochemical anal-
ysis because neurons need to be individually microinjected.
This was a limitation in assessing the mechanism by which
Kalirin affects neuronal process extension. Furthermore, sym-
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pathetic neurons require NGF for survival, another limitation
in using this model to analyze the effect of Kalirin on neuro-
trophic factor-induced signaling and neurite outgrowth. The
rat pheochromocytoma (PC12) cell line is a prototypical model
for examining NGF-induced process extension and was tested
as a model to study the role of Kalirin in this process (32). We
first determined whether the levels of endogenous Kalirin in
PC12 cells could be reduced using a dual-promoter construct
that coexpresses GFP and Kalirin antisense RNA (GFP/Kal-
as). Western blot analysis with a pan-Kalirin antiserum (37)
confirms that PC12 cells contain immunoreactive bands of 188,
268, and 336 kDa corresponding to the predicted molecular
masses of Kal7, Kal9, and Kal12 isoforms that arise by alter-
native splicing (Fig. 1A) (22). As expected, the 336-kDa band
was also detected with a Kal12-specific antiserum (data not
shown). Introducing GFP/Kal-as into dissociated or slice prep-
arations of rat hippocampus reduces Kalirin immunostaining
(28). Transfection of PC12 cells with this GFP/Kal-as construct
exhibited a dose-dependent reduction in expression of endog-
enous Kal7, Kal9, and Kal12 and correspondingly increased
expression of GFP, indicating that this construct can be used to
assess the effect of reduced Kalirin levels in PC12 cells (Fig.
1A).
PC12 cells transfected with the GFP/Kal-as or a GFP ex-
pression construct were treated with NGF for 2 days and ex-
amined by immunofluorescence microscopy, and cells with no
neurites or those with neurites longer than one cell body were
scored. We also transfected cells with a control GFP/peptidyl
amidating monooxygenase antisense RNA construct (GFP/
Control-as) that was previously used as an antisense specificity
control in hippocampal neurons (28). Seventy-two percent and
68% of the fluorescent cells transfected with the GFP or GFP/
Control-as construct, respectively, had neurites more than one
cell body long (Fig. 1B). In contrast, only 18% of PC12 cells
expressing GFP/Kal-as had neurites more than one cell body
long. These data indicate that reduced Kalirin levels signifi-
cantly inhibited NGF-induced process extension from PC12
cells, and they validate this system as a model with which to
investigate the effects of Kalirins on neurite outgrowth.
Kalirin is critical for NGF-stimulated TrkA phosphoryla-
tion. Since reduced Kalirin expression levels inhibited NGF-
induced neurite outgrowth, we wanted to better understand
the mechanism. NGF binds the TrkA and p75 receptors. Tyr499
is one of several tyrosine residues in TrkA that are autophos-
phorylated upon NGF stimulation, and Western blot analysis
with a phospho-TrkA/Tyr499 (P-TrkA) antibody can be used as
an indirect measure of TrkA activation (19). PC12 cells trans-
fected with expression constructs for GFP, GFP/Kal-as, or
GFP/Control-as were treated with NGF, and extracts were
analyzed by Western blotting with the phospho-TrkA antibody.
In PC12 cells transfected with control GFP or GFP/Control-as,
a rapid increase in TrkA phosphorylation was observed after
treatment with NGF (Fig. 2A). The mature 140-kDa form of
TrkA was phosphorylated, while no phosphorylation of the
immature 110-kDa TrkA was observed, despite higher expres-
sion of the 110-kDa form; the changes in molecular mass
reflect maturation of glycosyl groups of TrkA (52). Conversely,
NGF-induced TrkA phosphorylation was significantly de-
creased in cells transfected with GFP/Kal-as. Expression of
Kalirin antisense RNA did not affect the levels of total TrkA in
cells. These results indicate that Kalirin plays an important role
in NGF-induced activation of TrkA in PC12 cells and that the
effects of Kalirin on process extension may be due, at least in
part, to effects on TrkA.
Kalirin potentiates NGF-induced TrkA phosphorylation
and increases TrkA kinase activity. To determine whether
overexpression of Kalirin affects NGF-induced TrkA phos-
phorylation, PC12 cells were transfected with expression con-
structs for GFP or different amounts of Kal5, and TrkA phos-
phorylation was measured in cells treated with NGF for 0 or 15
min. We decided to focus on Kal5 (also called Kal7 [22])
FIG. 1. Antisense Kalirin RNA inhibits NGF-induced neurite out-
growth in PC12 cells. (A) A dual-promoter GFP/Kalirin antisense
construct reduces levels of endogenous Kalirin in PC12 cells. PC12
cells were transfected with a dual-promoter construct that coexpresses
GFP and Kal-as. Cell extracts were analyzed by Western blotting (WB)
with pan-Kalirin and GFP antibodies. (B) PC12 cells were transfected
with expression constructs for GFP, a control GFP/peptidyl amidating
monooxygenase antisense RNA construct (GFP/Control-as), or GFP/
Kal-as and treated with 50 ng/ml NGF for 2 days. Cells expressing GFP,
as visualized by immunofluorescence microscopy, were scored as cells
with neurites longer than one cell body or with no neurites. Bars, 10 m.
Standard deviations are for four experiments (n  50). The asterisk
indicates that cells expressing GFP/Kal-as have significantly fewer neu-
rites than the GFP and GFP/Control-as samples (P  0.001; H  23.1).
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because it is one of the shortest isoforms and lacks 12 of the 19
domains found in the longest isoform, Kalirin 12 (22). In con-
trol cells transfected with GFP, low basal TrkA phosphoryla-
tion was observed and increased phosphorylation occurred in
cells treated with NGF (Fig. 2B). A bar graph shows the rel-
ative ratios of P-TrkA to TrkA. Western blot analysis with a
tubulin antibody confirmed equal loading of extracts.
In contrast to PC12 cells transfected with the GFP control,
those transfected with a Kal5 expression construct exhibited
four major differences. Firstly, basal TrkA phosphorylation was
slightly elevated. Secondly, Kal5 expression produced a higher
level of NGF-induced phosphorylation of TrkA. Thirdly, in-
creasing Kal5 expression produced a rapid, dose-dependent
decrease in total TrkA content in cells after a 15-min treatment
with NGF. Finally, higher levels of Kal5 expression correlated
with an increased P-TrkA/TrkA ratio. Thus, Kal5 overexpres-
sion increased the amount of Tyr499 phosphorylation per TrkA
molecule in NGF-treated PC12 cells. These results demon-
strate that Kalirin induces and potentiates the activation of
TrkA.
In the absence of NGF ligand, expression of Kalirin in-
creases TrkA phosphorylation. There are several ways in which
Kalirin overexpression could increase levels of TrkA phos-
phorylation, one being an effect on TrkA kinase activity. To
determine whether Kal5 influences the kinase activity of TrkA,
human embryonic kidney 293 cells were cotransfected with
TrkA cDNA and either Kal5 cDNA or an empty vector, and
immune complex kinase assays were performed on immuno-
precipitated TrkA (Fig. 2C). The tyrosine kinase activity of
TrkA was found to be stimulated by Kal5 when a synthetic
FIG. 2. Kalirin is important for NGF-induced TrkA phosphorylation. (A) PC12 cells transfected with pCMS expression constructs for GFP,
GFP/Kal-as, or GFP/Control-as (1.0 g) were treated with NGF at 25 ng/ml for 15 min and analyzed by Western blotting (WB) with P-
TrkA(Tyr499), TrkA, and tubulin antibodies. Western blot analysis with a tubulin antibody shows relatively equal loading of samples. (B) Effect of
Kal5 on NGF-induced TrkA phosphorylation. PC12 cells were transfected with expression constructs for GFP (2.0 g) or Kal5 (low [0.2 g] or
high [2.0 g]). Cells were stimulated with NGF for 0 or 15 min. Results of Western blot analyses with antibodies to P-TrkA(Tyr499), TrkA, tubulin,
and myc are shown. Expression of myc-tagged Kal5 was confirmed with an anti-myc antibody. The bar graph shows levels of P-TrkA relative to
those of TrkA in samples. (C) Enzymatic activation of TrkA by Kal5. 293 cells (150-mm dishes) were transfected with 1 g of TrkA cDNA and
9 g of either Kal5 cDNA or an empty vector. Control dishes were transfected with the empty vector alone. TrkA was immunoprecipitated from
cell lysates using the anti-TrkA monoclonal antibody B-3 (Santa Cruz Biotech), and kinase assays were performed as described in Materials and
Methods. Slurries containing the washed immunoprecipitates (IPs) were aliquoted, and a Shc peptide (residues 309 to 327) kinase assay, an
autokinase assay ([32P]ATP only), and WB were performed. The bar graph represents incorporation of 32P into the Shc peptide in experiments
performed in triplicate (means 	 standard errors of the means). The asterisk indicates significant difference (P  0.001). Autoradiography
represents incorporation of 32P into TrkA (autokinase). Expression of Kal5 was confirmed by Western blotting. Control immunoprecipitates from
empty-vector samples (no TrkA cDNA) did not contain significant kinase activity (data not shown).
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peptide derived from the TrkA substrate Shc (containing Y317)
was used as an exogenous substrate in in vitro kinase assays
(Fig. 2C, bar graph). TrkA autokinase activity was measured by
the addition of radiolabeled ATP alone and demonstrated that
TrkA isolated from cells which expressed Kal5 was catalytically
activated relative to TrkA from cells which did not express
Kal5 (Fig. 2C, autoradiography). Thus, coexpression of TrkA
and Kal5 in cells results in enzymatic activation of the TrkA
tyrosine kinase.
Kalirin expression is important for TrkA phosphorylation in
PC12 cells, but it is not clear whether Kalirin acts similarly in
neurons. Both Kalirin and TrkA are known to be expressed in
olfactory bulb neurons (6, 16, 37). Olfactory bulb neurons were
transfected with GFP/Kal-as, treated with NGF for 15 min, and
immunostained for phospho-TrkA (Fig. 3). As expected, un-
transfected olfactory bulb neurons that were stimulated with
NGF had phospho-TrkA immunostaining in the cell body;
however, neurons expressing GFP/Kal-as and stimulated with
NGF had little phospho-TrkA immunostaining. Quantitation
of these results indicates that P-TrkA immunostaining in cells
expressing Kalirin antisense is significantly reduced relative to
that in control cells expressing GFP or GFP/Control antisense
RNA (Fig. 3, bar graph). These results indicate that Kalirin is
important for phosphorylation of TrkA in olfactory bulb neu-
rons.
Expression of Kalirin increases NGF/TrkA-mediated acti-
vation of CREB in 293 cells. Tyr499 of TrkA is phosphorylated
upon NGF stimulation and recruits adaptor proteins such as
Shc for signaling through the MAPK pathway to activate sev-
eral transcription factors including cyclic AMP-responsive el-
ement binding protein (CREB) (8, 9, 21, 47, 54). Therefore, we
would expect that Kalirin may potentiate activation of CREB
by NGF, since Kalirin potentiates NGF-induced phosphoryla-
tion of TrkA on Tyr499. 293 cells were used as a model with
which to study the effects of Kalirin on TrkA signaling to
CREB for several reasons. These cells lack endogenous TrkA,
Kalirin, and p75; p75 is a neurotrophin receptor which het-
erodimerizes with TrkA and is present in neurons and PC12
cells. Since Kalirin is thought to also bind the p75 receptor
(S. O. Yoon, unpublished results), the presence of p75 would
confound interpretation of similar experiments in neurons or
PC12 cells (58). In transfected 293 cells, TrkA was previously
shown to undergo NGF-induced autophosphorylation and sig-
naling through the MAPK pathway in a manner similar to that
in neurons (17). Also, the CREB luciferase reporter assay
requires cotransfection of several plasmids, and 293 cells have
higher transfection efficiencies than PC12 cells and neurons.
To determine whether Kalirin influences TrkA signaling, we
adapted a signal transduction CREB reporter assay using 293
cells expressing transfected TrkA; several controls were per-
formed to establish this assay (see Materials and Methods).
Since overexpression of TrkA is known to induce its autoacti-
vation, the TrkA expression plasmid was titrated to identify
expression levels that produced low basal TrkA phosphoryla-
tion and activation of CREB while generating a maximal NGF-
induced response (data not shown) (25).
The levels of Kal5 expression affected the extent of poten-
tiation of NGF-induced activation of a CREB reporter (Fig.
4A). In 293 cells transfected with a TrkA expression construct,
CREB was stimulated fivefold by NGF. When cotransfected
FIG. 3. Kalirin antisense RNA reduces TrkA phosphorylation in
neurons. Primary olfactory bulb neurons transfected with dual-pro-
moter GFP, GFP/Kal-as, or GFP/Control-as constructs were treated
with NGF (50 ng/ml) for 15 min and immunostained with a P-TrkA
antibody (red). GFP fluorescence, immunostaining, and phase-con-
trast pictures are shown for cells transfected with GFP/Kal-as. Unfilled
arrows indicate a transfected cell (green), and filled arrowheads depict
untransfected cells. The bar graph represents the percentage of neu-
rons expressing GFP with strong P-TrkA immunostaining. Strong im-
munostaining is considered clearly above background staining, and a
representative strongly immunostained neuron is shown (filled arrow-
heads). The asterisk indicates that the number of cells with strong
P-TrkA immunostaining was significantly lower for cells expressing
GFP/Kal-as relative to cells expressing GFP or GFP/Control-as (P 
0.05).
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with TrkA, increasing levels of Kal5 cDNA produced a dose-
dependent potentiation of NGF-induced reporter activation,
with a maximal 12-fold activation. The levels of CREB re-
porter activation in cells transfected with 200 and 400 ng of the
Kal5 expression construct were significantly higher than basal
levels and levels in NGF-stimulated cells not transfected with

al5 cDNA. Minimal activation of the CREB reporter was
observed in cells transfected with Kal5 alone. These results
demonstrate that Kal5 expression increased NGF/TrkA-in-
duced activation of a CREB reporter; they are consistent with
the observation that Kalirin potentiates NGF-induced TrkA
phosphorylation (Fig. 2B); and they strongly suggest that Ka-
lirin enhances NGF-induced transcriptional activation.
We next examined whether Kal5 affected NGF-induced
phosphorylation of endogenous CREB on Ser133, a residue
that, when phosphorylated, activates CREB-mediated tran-
scription. 293 cells cotransfected with TrkA and varying levels
of a Kal5 plasmid were treated with NGF for 15 min. CREB
phosphorylation was measured indirectly by Western blot anal-
ysis comparing blots probed with phospho-Ser133 CREB and
pan-CREB antibodies. Control cells possessed low basal
CREB phosphorylation that was enhanced by treatment with
NGF for 15 min (Fig. 4B). As in the CREB reporter assay,
dose-dependent increases in NGF-induced CREB phosphory-
lation were observed with increasing levels of Kal5 expression,
as assessed with a myc antibody. These experiments indicate
that expression of Kal5 enhances TrkA signaling to CREB.
Kalirin potentiates NGF-stimulated Mek phosphorylation.
Activation of CREB can be mediated through the MAPK,
protein kinase C, or other signaling pathways (46). Kalirin
increased the NGF-induced activation of CREB, and TrkA
signals through the MAPK pathway to activate CREB, but we
did not know whether Kalirin influences NGF-induced activa-
tion of the MAPK pathway (8, 9, 21, 47, 54). We next examined
the effects of Kalirin overexpression on MAPK pathway acti-
vation in PC12 cells. PC12 cells transfected with expression
constructs for Kal5 or an empty vector were stimulated with
NGF for 15 min and analyzed for Mek phosphorylation as a
measure of MAPK pathway activation. Cell lysates were ana-
lyzed by Western blotting with an activation-specific Mek1/2
(P-Mek) antibody directed against phospho-Ser217/221 (Cell
Signaling). As expected, P-Mek was detected in cells stimu-
lated with NGF (Fig. 5A). No activated Mek was observed in
lysates derived from cells transfected with the Kal5 expression
construct alone (no NGF). However, cells expressing Kal5 and
stimulated with NGF possessed significantly higher activated
P-Mek levels than control cells (no Kal5) stimulated in the
same manner, indicating a potentiated response. These data
support the previously observed increases in NGF-induced
CREB activation by Kal5 in 293 cells and provide evidence that
Kal5 potentiates TrkA signaling through the MAPK pathway.
Overexpression of Kalirin enhances the responsiveness of
PC12 cells to TrkA-mediated neurite outgrowth. Since Kal5
potentiated TrkA autophosphorylation and activation of Mek
in PC12 cells, we wanted to know whether Kalirin overexpres-
sion could sensitize PC12 cells to neurite outgrowth elicited by
NGF. In the absence of NGF, PC12 cells transfected with a
Kal5 expression construct or the dual-promoter Kal5/GFP ex-
pression construct did not produce neurite outgrowth that was
significantly different from that in nontransfected cells or cells
transfected with an empty vector (data not shown). This result
was not surprising, considering that Kal5 overexpression did
not increase P-Mek levels in unstimulated cells. We next ex-
amined whether Kal5 might potentiate neurite outgrowth in
PC12 cells treated with a low dose of NGF (2 ng/ml). PC12
cells transfected with a Kal5/GFP expression plasmid and stim-
ulated with 2 ng/ml of NGF produced neurites longer than one
cell body in 17% of the cells, significantly more than control
cells expressing GFP and treated with NGF (7.1% [Fig. 5B]).
Without NGF, cells transfected with the GFP or Kal5/GFP
FIG. 4. Kalirin expression increases NGF-induced activation of
CREB. (A) Signal transduction reporter assay for assessing the effect
of Kal5 on TrkA signaling. 293 cells were cotransfected with expression
constructs for TrkA (25 ng), a Gal-dbd/CREB-TD chimera (40 ng),
-galactosidase (10 ng), varying amounts of Kal5, and a Gal4-lucif-
erase reporter plasmid (400 ng). An empty pEAK10 vector was added
such that each sample had the same amount of DNA. Cells were
treated with NGF (25 ng/ml) for 6 h where indicated. Luciferase
activities of cell extracts were normalized to -galactosidase activity,
and fold activation was relative to samples not cotransfected with Kal5
or treated with NGF. Standard deviations were calculated from trip-
licate observations from four experiments. Asterisks indicate that the
200- and 400-ng samples were significantly different from the samples
with no Kal5 and with or without NGF in a one-way ANOVA (P 
0.05). Western blot analysis (WB) confirmed that TrkA levels are
constant and that increasing amounts of transfected Kal5 cDNA pro-
duced increased expression of Kal5 protein (bottom panels). (B) WB
of 293 cells cotransfected with expression constructs for TrkA and
varying amounts of Kal5, or with an empty pEAK10 vector (lanes 1 and
2). Cells were treated with 25 ng/ml NGF for 15 min, harvested in
SDS-PAGE lysis buffer. and probed with antibodies for phospho-
Ser133 CREB to assess CREB activation, CREB (total CREB), and
Myc (Kal5).
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expression construct yielded only 4 to 5% of cells with neurites.
These experiments demonstrate that overexpression of Kal5
increases the sensitivity of PC12 cells to NGF-induced process
extension.
TrkA and Kalirin colocalize in neurons. The effects of
Kalirin on neurite outgrowth and TrkA signaling imply that
Kalirin and TrkA colocalize in neurons. Primary neuronal cul-
tures prepared from P1 dorsal root ganglia (DRG) and olfac-
tory bulbs were immunostained with pan-Kalirin and TrkA
antibodies and examined by deconvolution fluorescence mi-
croscopy. Small puncta could be resolved in axons of DRG
neurons (Fig. 6A). Several of these puncta were immuno-
stained with antibodies to Kalirin, TrkA, or both proteins.
While these results indicate that Kalirin and TrkA are colo-
calized in axons, little colocalization was observed in the neu-
ronal cell soma (data not shown). Similar colocalization of
Kalirin and TrkA was observed in processes of olfactory bulb
neurons (Fig. 6B). In contrast to DRG neurons, Kalirin and
TrkA were also colocalized in the perinuclear region of the
neuronal cell soma of olfactory bulb neurons (Fig. 6C).
Kalirin binds in a complex with TrkA and phospho-TrkA.
To determine whether Kalirin and TrkA are present in the
same complex in vivo, coimmunoprecipitation experiments
were performed. Large projection neurons in adult rodents
express low levels of both Kalirin and TrkA, making it difficult
to determine whether endogenous Kalirin and TrkA colocalize
(4, 15). During development, when neurons are establishing
connections, both TrkA and Kalirin are expressed at higher
levels, so we used lysates prepared from an E17 embryonic
mouse brain for coimmunoprecipitation analysis. Kal12 (336
kDa), Kal9 (268 kDa), and Kal7 (188 kDa) isoforms present in
embryonic mouse brain were coimmunoprecipitated with
TrkA but not with an isotype-matched control antibody (Fig.
7A) (22). Probing of blots with a TrkA antibody confirms
immunoprecipitation of TrkA by the TrkA antibody. Approx-
imately 5% of the input Kalirin was coimmunoprecipitated
with TrkA. This result demonstrates that neuronal Kalirin and
TrkA exist in the same protein complex in vivo.
To determine if the phosphorylated, activated form of TrkA
binds in a complex with Kalirin, we used 293 cells transfected
with a large amount of TrkA cDNA (1 g) that induces con-
stitutive TrkA autophosphorylation and abundant phospho-
TrkA levels. Lysates from 293 cells cotransfected with a TrkA
expression construct and a plasmid encoding the Kal5 cDNA
were immunoprecipitated with myc or control antibodies and
analyzed by Western blotting with phospho-TrkA and myc
antibodies. The mature 140-kDa phospho-TrkA coimmuno-
precipitated with myc-tagged Kal5 (myc antibody) but not with
a control IgG1 antibody, confirming the specificity of the anti-
myc immunoprecipitation (Fig. 7B). Furthermore, no detect-
able P-TrkA was immunoprecipitated with the myc antibody
when extracts expressing TrkA alone were used. These results
indicate that Kalirin can form a complex with the phosphory-
lated TrkA receptor.
TrkA binds specifically to the N-terminal PH domains of
Kalirin and Trio. To identify a domain(s) in Kal5 important
for interaction with TrkA, different fragments of Kal5 were
expressed in E. coli as GST fusion proteins, purified, and used
in GST pulldown experiments. Extracts prepared from 293
cells transfected with a large amount of a TrkA expression
plasmid (1 g) were incubated with purified GST fusion pro-
teins, and complexes were pulled down with glutathione
Sepharose and analyzed by Western blotting with a TrkA an-
tibody. TrkA bound to the PH domain of Kal5, whereas no
detectable binding was observed for GST alone or for other
parts of Kal5 (Fig. 7C, top panel). In addition, phospho-TrkA
present in these extracts specifically bound to the PH domain
of Kal5 (Fig. 7C, center panel). Approximately 77 and 100% of
the TrkA and phospho-TrkA present in extracts bound to
Kal5-PH, respectively. Analysis of a Coomassie-stained gel
confirmed relatively equal loading of GST and GST fusion
proteins in this experiment (Fig. 7C, bottom panel). Thus,
Kal5-PH binds both TrkA and phospho-TrkA.
While Kal5 has only one PH domain, several alternatively
spliced Kalirin isoforms and a Kalirin homologue, Trio, con-
tain two PH domains. To determine whether the interaction of
TrkA with the Kalirin N-terminal PH domain (PH1, present in
Kal5) was specific, binding of TrkA to GST fusion proteins
containing each of the PH domains of Kalirin and Trio was
assessed using a GST pulldown assay. TrkA bound to both
Kalirin and Trio N-terminal PH domains, whereas no substan-
tial binding to either C-terminal PH domain (PH2) or GST
alone was observed (Fig. 7D). The Kalirin and Trio PH1 do-
mains that bind TrkA have 85% amino acid identity. This
FIG. 5. Effect of Kalirin overexpression on NGF-induced Mek
phosphorylation and neurite outgrowth in PC12 cells. (A) Kal5 poten-
tiates NGF activation of the MAPK pathway. PC12 cells transfected
with the indicated constructs under basal conditions or stimulated with
50 ng/ml NGF for 15 min were analyzed by Western blot (WB) analysis
with phospho-Mek1/2 and pan-Mek1/2 antibodies. (B) PC12 cells
transfected with a dual-promoter GFP/Kal5 expression construct
(Kal5) or an empty vector for GFP expression were treated with 2
ng/ml NGF in serum-free medium for 2 days and scored for neurite
outgrowth. The bar graph shows the percentage of transfected cells
with neurites (n  50), with standard deviations from triplicate obser-
vations. The asterisk indicates that cells transfected with the Kal5/GFP
expression construct and treated with NGF had significantly more
neurites than cells under other conditions (P  0.05; H  7.88).
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experiment indicates that not all RhoGEF PH domains have
the ability to bind TrkA and demonstrates a degree of speci-
ficity in the Kal5-PH—TrkA interaction.
Overexpression of Kalirin enhances NGF-induced activa-
tion of Rac. The PH and DH domains of Kalirin comprise the
Kalirin N-terminal GEF domain, which catalyzes guanine nu-
cleotide exchange and activation of Rac1 and RhoG (32, 38).
Since PH domains are often involved in regulation of GEF
activity and TrkA binds the Kalirin PH domain, Kalirin may be
a RhoGEF that mediates the effects of NGF on Rac (59).
Stimulation of PC12 cells with NGF induces rapid activation of
Rac, and Kalirin can activate Rac in vitro and in cells (38, 40).
To determine if Kalirin plays a role in the NGF-induced
activation of Rac, PC12 cells were transfected with a GFP or
Kal5 expression construct and assayed for levels of activated
Rac/GTP. Cells were treated with NGF as indicated, and Rac
activation was assessed using an established effector binding
assay with a PAK-PBD–GST fusion protein (3). Control cells
transfected with GFP showed low basal Rac activation that
increased after 2 and 10 min of NGF stimulation (Fig. 8),
consistent with previously reported rapid NGF-induced Rac
activation (40). Overexpression of Kal5 led to Rac activation,
and NGF stimulation increased Rac activation to levels higher
than those observed in cells expressing the GFP control. The
FIG. 6. Kalirin colocalizes with TrkA in neurons. (A) Immunostaining of a neuronal axon from a primary dorsal root ganglion culture with a
pan-Kalirin antiserum and a TrkA antibody. Colored arrows indicate whether puncta are stained for endogenous Kalirin (red), endogenous TrkA
(green), or both (yellow). (B and C) Primary olfactory bulb cultures immunostained with TrkA (green) and pan-Kalirin (red) antibodies, indicated
by colored arrows; yellow arrows indicate colocalization. A higher magnification of the process in the white box in panel C is shown in panel B.
For all microscopy experiments, Z-stacks were collected and images were deconvolved.
VOL. 25, 2005 Kalirin AFFECTS TrkA 5113
specificity of the assay for GTP-bound Rac was demonstrated
by binding of Rac to the PAK-PBD–GST fusion protein in the
presence of excess GTPS, whereas no binding was detected in
the presence of excess GDP. These results demonstrate that
Kalirin overexpression in PC12 cells can increase Rac activa-
tion in response to NGF.
DISCUSSION
Initiation and outgrowth of axons from sympathetic neurons
are known to be induced by Kalirin expression and blocked by
antisense Kalirin oligonucleotides (32). We found that endog-
enous Kalirin in PC12 cells is important for neurite outgrowth,
with reduced levels inhibiting and overexpression potentiating
neurite outgrowth at a low dose of NGF (Fig. 1 and 5). These
experiments indicate that PC12 cells are a good model with
which to investigate the mechanism by which Kalirin induces
axonal growth. The experiments and results discussed below
support the model shown in Fig. 9 and provide a mechanistic
explanation for Kalirin’s effects on neurite outgrowth.
Kalirin plays an important role in NGF-induced activation
of TrkA. Several pieces of evidence suggested that Kalirin
might affect one of the NGF receptors or downstream signal
transduction pathways. We first examined whether Kalirin af-
fected activation of TrkA, a receptor that transmits the NGF
signal across the plasma membrane in cells. Reduced Kalirin
expression decreased NGF-induced TrkA phosphorylation on
Tyr499, while Kal5 overexpression increased the level of NGF-
induced TrkA phosphorylation.
There are several possible mechanisms by which Kalirin
FIG. 7. TrkA interacts with the Kalirin PH domain. (A) Cell lysates prepared from a mouse E17 brain homogenate were immunoprecipitated
with TrkA or control antibodies (IP Ab). The immune complexes were captured on protein G-Sepharose, washed, and boiled in SDS-PAGE
sample buffer. Immunoprecipitated TrkA and coimmunoprecipitated Kalirin isoforms were detected by Western blotting (WB) with TrkA and
pan-Kalirin antibodies. The input sample represents 13% of the extract that was immunoprecipitated. (B) Cell lysates prepared from 293 cells
cotransfected with an expression construct for TrkA (1 g) and either a construct expressing Kal5 or an empty vector (1 g) were immunopre-
cipitated with myc or isotype control IgG1 antibodies. Immunoprecipitated myc-tagged Kal5 and coimmunoprecipitated P-TrkA were detected by
WB with myc and P-TrkA (phospho-Tyr499) antibodies, respectively. (C) Mapping of Kalirin domains that bind TrkA by a GST pulldown assay.
Extracts prepared from 293 cells transfected with a TrkA expression construct (1 g) were incubated with GST or a GST-Kalirin domain chimera.
Protein complexes were applied to glutathione Sepharose beads, which were washed, and bound proteins were analyzed by WB with TrkA and
P-TrkA antibodies. Bottom panel shows a Coomassie-stained gel of GST and the GST-Kalirin chimera. Input represents 67% of cell lysates applied
to GST fusion proteins in binding assays. A schematic diagram of Kal5 with domains labeled is provided. (D) TrkA binds specifically to the N-
terminal PH domains of Kalirin and Trio. GST pulldown assays were performed as for panel C by using the GST or GST-PH fusion proteins in-
dicated and WB analysis with a TrkA antibody (Chemicon). A Coomassie-stained gel shows fusion proteins used in the GST pulldown experiment.
FIG. 8. Kalirin overexpression increases NGF-induced activation
of Rac in PC12 cells. PC12 cells transfected with GFP or Kal5 expres-
sion constructs were stimulated with 50 ng/ml NGF for the times
indicated. Cell extracts were assessed for activation of Rac by a pull-
down assay with a PAK-PBD GST fusion protein that recognizes Rac
with GTP bound and Western blot analysis with a Rac antibody.
Western blot analysis of input samples is shown.  indicates a positive
control where extracts are incubated with GTPS, and  indicates a
negative control where extracts are incubated with GDP.
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could affect the levels of NGF-induced TrkA phosphorylation
in cells. Kal5 may alter the localization of TrkA in cells. While
Kal5 expression does not affect the levels of TrkA expression in
PC12 cells (Fig. 2B and 4A), NGF stimulation of cells overex-
pressing Kal5 shows rapid disappearance of TrkA compared to
control cells (Fig. 2B). This result could be explained by Kal5
affecting increased activation, internalization, and/or routing of
TrkA to lysosomes. This will need to be investigated further.
We also cannot rule out the possibility that, in the presence of
Kal5, a higher proportion of TrkA could be available on the
cell surface for ligand stimulation. If TrkA were maintained
inactive by a phosphorylation/dephosphorylation turnover in
unstimulated cells, then inhibition of tyrosine phosphatases or
protection of phospho-TrkA sites by Kalirin would also result
in increased TrkA activation.
Some of these mechanisms may contribute to increased
TrkA phosphorylation in cells. However, immunoprecipitated
TrkA had increased tyrosine kinase activity when isolated from
cells overexpressing Kal5, supporting a mechanism whereby
Kalirin enhances TrkA catalytic function and thus autophos-
phorylation. Consistent with this hypothesis, in the absence of
NGF, PC12 cells transfected with Kalirin exhibit increased
levels of phospho-TrkA compared to transfected control cells.
Kalirin could influence TrkA activation by several mecha-
nisms. NGF induces TrkA dimerization, so Kalirin could in-
fluence TrkA dimerization by increasing the rate of dimeriza-
tion or altering the stability of homodimers. Alternatively,
Kalirin could influence the conformation of TrkA, rendering
the receptor more prone to autophosphorylation or increasing
the accessibility to the substrate. Although effects of cytosolic
proteins on TrkA autokinase activity have not been docu-
mented, a monovalent NGF ligand that does not induce re-
ceptor dimerization induces enough, albeit attenuated, TrkA
phosphorylation to drive neurite outgrowth in PC12 cells (30).
This study indicates that, in addition to receptor dimerization,
there are other mechanistic components of TrkA activation.
Kalirin enhances activation of the MAPK pathway by TrkA.
Upon engaging ligand, Tyr499 is one of the TrkA residues that
is autophosphorylated. Elevated Kalirin expression potenti-
ated NGF-induced phosphorylation of Tyr499 in intact cells
and increased TrkA kinase activity toward an Shc peptide
substrate in immune complex kinase assays. Consistent with its
effect on TrkA kinase activity, elevated Kal5 also potentiated
NGF-induced phosphorylation of Mek, a downstream target in
the MAPK pathway. Like Kalirin’s effect on TrkA, other cy-
tosolic proteins are known to influence the activation of recep-
tor tyrosine kinases and the MAPK pathway. APS and SH2B
adaptor proteins potentiate insulin-induced autophosphoryla-
tion of the insulin receptor and TrkA and also potentiate
MAPK activation (1, 2, 41). There is an interesting correlation
with these proteins having PH domains, the domain in Kalirin
that interacts with TrkA.
Our experiments provide a mechanistic explanation as to
why process outgrowth in PC12 cells and sympathetic neurons
is blocked by antisense Kalirin RNA. Kalirin is important for
NGF-induced TrkA kinase activation (Fig. 2), TrkA phosphor-
ylation is required for signaling to the MAPK pathway, and the
MAPK pathway is required for neurite extension (19, 56).
While our experiments with Kalirin focused on TrkA, which is
expressed mostly in neurons of the forebrain and periphery,
Kalirin may similarly affect TrkB and TrkC, which are more
widely expressed in cortical and hippocampal neurons. Kalirin
overexpression in cortical neurons increases dendritic spine
density (36, 39). Kalirin-induced TrkA phosphorylation may
play a role in spine formation, since Trk receptors are involved
in the maintenance of dendrites, and activation of the MAPK
pathway is critical for dendritic filopodia and spine extensions
(28, 53). Likewise, our observation that reduced Kalirin levels
inhibit NGF-induced TrkA phosphorylation might explain why
expression of antisense Kalirin RNA reduces dendrite length
in dissociated and slice preparations of hippocampal neurons
(28). Since Kalirin appears to play a role in NGF-induced
activation of the MAPK pathway and CREB, its localization in
spines may also be involved in long-term potentiation and
memory, which requires sustained MAPK activation (53).
Kalirin binds to and colocalizes with TrkA. Several experi-
ments support an interaction of Kalirin with TrkA. Kalirin and
TrkA coimmunoprecipitate from the brain, the Kalirin PH
domain binds to TrkA in vitro, and these proteins colocalize
with each other in neurons. While these experiments indicate
that Kalirin is in the same complex with TrkA, a GST pulldown
assay demonstrated that purified Kal5 binds to the purified
GST-TrkA cytosolic domain, suggesting that this interaction is
direct; however, this GST-TrkA produced in bacteria had no
detectable kinase activity (data not shown). Nevertheless, the
TrkA receptor is the first receptor found to associate with
Kalirin, and this represents a major step in understanding the
function of Kalirin.
FIG. 9. Model of Kalirin’s effects on TrkA signaling and neurite
outgrowth. Kalirin is critical to NGF-induced TrkA phosphorylation
and neurite outgrowth. Kalirin overexpression also enhanced NGF-
stimulated activation of MAPK, CREB, and Rac. Rac activation in-
duces formation of lamellipodia, the first morphological change in-
duced by NGF in PC12 cells and a precursor of neurites (40).
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Kalirin binds to TrkA though its PH domain. The interac-
tion of TrkA with Kalirin is also supported by experiments
mapping the Kalirin domains mediating this interaction. Do-
main-mapping experiments indicate that TrkA binds to the PH
domain of Kalirin. While Kal-PH bound TrkA, the DH/PH
fragment containing this PH domain did not. The DH/PH is
enzymatically active as a RhoGEF, indicating that DH/PH
folds properly (38, 43). Therefore, the inability of the Kalirin
DH/PH to bind the receptor is consistent with a sequestered
TrkA binding site in its PH domain. Other protein-protein
interactions or binding of phosphoinositide lipids to the PH
domain may be required to liberate the TrkA binding site.
Phosphoinositide 3-kinase, an enzyme that binds the TrkA
receptor, is activated in response to NGF stimulation, produc-
ing phosphatidylinositol(3,4,5)trisphosphate, and is required
for neurite outgrowth (20). Binding of phosphoinositides or
other molecules to the Kalirin PH domain may increase GEF
activity toward Rac. Although we do not know if the Kalirin
PH domain is accessible to phosphoinositides when bound to
TrkA, it is likely that TrkA-bound Kalirin is localized at the
cytoplasmic side of the plasma membrane in close proximity to
phosphoinositides. The potential coupling of the TrkA recep-
tor to Rac activation through Kalirin is interesting because
within the first few minutes of NGF stimulation, PC12 cells
flatten into lamellipodia in a Rac-dependent manner (40).
Consistent with the potential linkage of TrkA/Kalirin to Rac
activation, overexpression of Kal5 enhances the NGF activa-
tion of Rac during the first 10 min of NGF stimulation.
Receptor-RhoGEF pairings may play an important role in
receptor activation and signal transduction. The interaction of
the Kalirin RhoGEF with a receptor is interesting because
several other RhoGEFs are known to associate with receptors
or receptor signaling pathways: the MER receptor interacts
with Vav1; the Ephrin A receptor interacts with ephexin; plate-
let-derived growth factor and epidermal growth factor recep-
tors interact with Vav1, Vav2, and Vav3; Tiam interacts with
Ephrin-B1 and EphA2; and Plexin B1 and IGF-1 receptors
interact with Larg (29, 33, 45, 48-50). One possibility is that
these receptor-RhoGEF pairings may be mediated through the
PH domains of the RhoGEFs, as is the case for TrkA/Kalirin.
In support of this hypothesis, mutation of the PH domain in
the RhoGEF Dbs inhibits its effects on signal transduction to
a serum response factor reporter (14). The interaction of Ka-
lirin with TrkA may be one example in an emerging theme of
receptor-RhoGEF pairings. In addition, G subunits bind to
the Sec14 domains of Kalirin, Trio, and Dbs RhoGEFs, thus
providing another way in which Kalirin may link to another
class of receptors, G-protein-coupled receptors (35).
The interaction of Kalirin with TrkA is mediated through its
N-terminal PH domain. PH domains have little amino acid
conservation and are present in nearly all RhoGEFs, making
them attractive targets for specific RhoGEF-receptor pairings.
Consistent with this hypothesis, the N-terminal PH domains of
Kalirin and its homologue Trio bind the TrkA receptor,
whereas the C-terminal PH domains do not. The N-terminal
PH domains have 85% amino acid identity, suggesting that
Kalirin and Trio bind to a common site(s) in TrkA. While
many tyrosine kinase receptor-associated proteins have PH
domains (e.g., PLC, Gab1, APS, SH2B, phosphoinositide
3-kinase, and IRS1-4), and the PH domain of PLC1 binds to
the insulin receptor (1, 2, 24, 27, 31, 42), this is the first report
of a PH domain from a RhoGEF interacting with a receptor
tyrosine kinase. It is noteworthy that the three-dimensional
fold of PH domains is very similar to phosphotyrosine binding
domains, such as that in Shc, which binds to a phosphotyrosine
in the juxtamembrane region of TrkA.
The interaction of the Trio PH domain with TrkA is also
interesting because Trio induces neurite outgrowth in PC12
cells in the absence of NGF (12). Unlike Trio, Kal5 did not
induce neurite outgrowth in PC12 cells; rather, it potentiated
the response of PC12 cells to NGF. This may be because
induction of neurites by Trio required its SH3 domain, which
is not present in the Kal5 isoform that we used in this study.
Nevertheless, the interaction of the Trio PH domain with TrkA
links the results of this paper to the studies of Trio in neurite
outgrowth.
In conclusion, we have found that Kalirin is in a complex
with TrkA, colocalizes with TrkA in neurons, and affects the
kinase activity of TrkA. The effects of Kalirin on TrkA and
NGF signaling provide a mechanistic explanation for Kalirin’s
effects on process extension in PC12 cells and sympathetic
neurons. The influence of Kalirin on TrkA activation also
provides an explanation for previously observed effects of Ka-
lirin on dendritic maintenance and spine formation. Domain-
mapping experiments indicate that the Kalirin PH domain
mediates the binding to TrkA. Although several RhoGEFs are
known to interact with receptor tyrosine kinases, Kalirin is the
first RhoGEF shown to bind to a receptor tyrosine kinase
through its PH domain. Since most RhoGEFs have PH do-
mains, this interaction may be an example of a more general
interaction scheme where the PH domains of RhoGEFs me-
diate interactions with specific receptor tyrosine kinases.
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